Cohencidence. I'm sure it was an accident. They're taking it very seriously.
Cohencidence. I'm sure it was an accident. They're taking it very seriously.
Pfizer notified the Kalamazoo Department of Public Services around 4:30 p.m. on Tuesday, March 12, that an estimated 1,057 gallons of methylene chloride had been released within the process area of the manufacturing facility located at 7000 Portage Road...
...While the water reclamation plant is designed and permitted to treat up to 291 gallons per day of methylene chloride, the total volume of methylene chloride that reached the plant following Tuesday’s release is still not known, the release states.
Source (mlive.com)
Cause the (((Disease)))
EPA Finds Methylene Chloride Poses an Unreasonable Risk to Human Health (epa.gov)
Estimating the risk of human cancer associated with exposure to methylene chloride (pubmed.ncbi.nlm.nih.gov)
Sell the (((Cure)))
U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer (pfizer.com)
> Pfizer notified the Kalamazoo Department of Public Services around 4:30 p.m. on Tuesday, March 12, that an estimated 1,057 gallons of methylene chloride had been released within the process area of the manufacturing facility located at 7000 Portage Road...
> ...While the water reclamation plant is designed and permitted to treat up to 291 gallons per day of methylene chloride, the total volume of methylene chloride that reached the plant following Tuesday’s release is still not known, the release states.
[Source](https://www.mlive.com/news/kalamazoo/2024/03/pfizer-chemical-spill-prompts-no-contact-advisory-of-kalamazoo-river.html)
Cause the (((Disease)))
[EPA Finds Methylene Chloride Poses an Unreasonable Risk to Human Health](https://www.epa.gov/chemicals-under-tsca/epa-finds-methylene-chloride-poses-unreasonable-risk-human-health)
[Estimating the risk of human cancer associated with exposure to methylene chloride](https://pubmed.ncbi.nlm.nih.gov/1820733/)
Sell the (((Cure)))
[U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer](https://www.pfizer.com/news/press-release/press-release-detail/us-fda-approves-pfizers-braftovir-mektovir-braf-v600e)
(post is archived)